Tag
By Naomi Creek
Do you use abatacept (Orencia®) to treat your inflammatory arthritis? We have been alerted about an anticipated shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations of abatacept. Here’s what you need to do.
By CreakyStaff
Were you transitioned to another medicine during the tocilizumab (Actemra®) shortage? Now that it is available again, you can speak with your rheumatologist about your ongoing treatment options.
By CreakyStaff
Do you use Orencia to treat your inflammatory arthritis? Have you been affected by the current supply shortage? Here are the options available to you.
What will the current COVID-19 vaccine candidates mean for Australians with autoimmune conditions? Can we take them? When will we get them?
Ixekizumab (Taltz®) is a new treatment option for Australians with ankylosing spondylitis - a chronic form of arthritis that affects the spine and pelvis.
By CreakyStaff
It can be a big adjustment to give yourself injections. These tips can make the process less scary.
By CreakyStaff
Do you use a biologic medication for your inflammatory arthritis? Do you know about biosimilars? Discover the basics as part of Biosimilar Awareness Week.
Axial spondyloarthritis (including ankylosing spondylitis) is a common form of arthritis, yet most Australians haven’t heard of it. CreakyJoints Australia would like to help change that.
By CreakyStaff
Upadacitinib (Rinvoq®) is a new treatment option now available for adults with moderate to severe RA who can't tolerate methotrexate or don't respond sufficiently to it.
What should you do if you can’t access Plaquenil? Are you at risk of COVID-19 exposure if you have a biologic infusion in a hospital? We’ve got the answers you’ve been seeking.
By 
